Can zopiclone induce delirium?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 23, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Zopiclone Induce Delirium?

Yes, zopiclone can induce delirium in older adults, and this risk is particularly elevated in elderly patients, those with dementia, and individuals who abruptly discontinue the medication after chronic use.

Mechanism and Risk Profile

Zopiclone, like other nonbenzodiazepine hypnotics (Z-drugs), shares pharmacologic properties with benzodiazepines despite its different chemical structure 1. The FDA labeling for eszopiclone (the active S-enantiomer of zopiclone) explicitly warns about cognitive and behavioral changes that may be serious or life-threatening 2. These medications are associated with confusion, disorientation, and memory impairment—all cardinal features of delirium.

Evidence for Delirium Induction

Direct Delirium Risk

  • Case reports document delirium after even a single dose of zopiclone in an 84-year-old patient 3, demonstrating that susceptible individuals can develop delirium with minimal exposure
  • The NICE delirium prevention guideline specifically identifies benzodiazepines and similar agents as potentially associated with delirium 4, leading to reluctance to recommend pharmacologic sleep enhancers in at-risk populations

Withdrawal-Induced Delirium

  • Abrupt discontinuation poses significant risk: A case report documented severe delirium in an elderly patient following abrupt zopiclone withdrawal, which completely resolved when the medication was resumed at lower doses 5
  • This mirrors findings with zolpidem, where abrupt cessation after chronic high-dose use resulted in acute delirium requiring benzodiazepine treatment 6

High-Risk Populations

The following groups face substantially elevated delirium risk:

  • Older adults (especially those ≥65 years): Glass and colleagues demonstrated a 5-fold increase in memory loss, confusion, and disorientation with sedative-hypnotics in older patients with insomnia 2
  • Patients with dementia: In a randomized trial of AD patients, 3 participants discontinued zopiclone due to intense daytime sedation and worsened agitation 7
  • Those with baseline cognitive impairment or multiple risk factors for delirium

Clinical Implications and Recommendations

Prescribing Considerations

When zopiclone must be used despite delirium risk:

  • Start with the lowest effective dose and monitor closely for cognitive changes
  • Avoid in patients with multiple delirium risk factors (advanced age, dementia, polypharmacy, acute illness)
  • Never discontinue abruptly in patients on chronic therapy—taper gradually to prevent withdrawal delirium 8
  • Limit duration: FDA approval is for short-term use, though many prescribe long-term despite lack of evidence 2

Monitoring

Watch specifically for:

  • Acute confusion or disorientation
  • Fluctuating consciousness
  • Increased agitation or behavioral disturbances
  • Next-morning cognitive impairment
  • Paradoxical worsening of sleep or daytime function

When Delirium Occurs

If delirium develops:

  1. Do not abruptly stop if patient has been on chronic therapy
  2. Consider gradual taper with benzodiazepine bridge if withdrawal suspected 5
  3. Evaluate for other precipitating factors (infection, metabolic derangement, other medications)
  4. In acute withdrawal delirium, benzodiazepines (e.g., lorazepam) may be required for stabilization 6

Important Caveats

The FDA label notes that zopiclone/eszopiclone can cause amnesia, confusion, and complex behaviors (sleep-driving, preparing food) while not fully awake 1. These effects are amplified by alcohol or other CNS depressants 1. The risk-benefit calculation becomes particularly unfavorable in older adults where observational data suggest associations with falls, fractures, and increased mortality 2.

The bottom line: Zopiclone definitively can cause delirium both through direct CNS effects and withdrawal, making it a poor choice for older adults and those with cognitive impairment where safer alternatives should be prioritized.

Related Questions

In a 70-year-old female on polypharmacy who is taking multiple psychotropic agents (including clonazepam for anxiety‑related restlessness and crying), which medication should be tapered first?
What is the safest way to manage a 74-year-old patient taking ambien (zolpidem) for insomnia?
In a 23‑year‑old woman who ingested 20 tablets of alprazolam 0.5 mg and 10 tablets of amlodipine 5 mg 24 hours ago, now neurologically intact (Glasgow Coma Scale E4 M6 V4) but drowsy, with blood pressure 120/80 mmHg, tachycardia (heart rate 120 bpm), respiratory rate 16/min, arterial oxygen tension 120 mmHg and carbon dioxide tension 40 mmHg, what aspects should the emergency physician evaluate and monitor?
How should I manage a patient whose acute symptoms resolved after lorazepam but who reports a possible allergic reaction to an unknown chemotherapy regimen two weeks ago?
What is the diagnosis and recommended medication management (dose and frequency) for a 62-year-old woman who abruptly stopped chronic alprazolam 1 mg five times daily and now presents with disorganized speech and seizures, while currently taking mirtazapine 45 mg nightly and lamotrigine 200 mg three times daily for seizures?
Can tranexamic acid be used to treat rectal bleeding in a breast cancer patient?
What are the off‑label indications for atomoxetine, including recommended dosing, titration schedule, monitoring parameters, and trial duration?
What is the recommended approach for a patient who cannot tolerate a higher fluoxetine dose while starting bupropion sustained‑release (150 mg twice daily)?
How should I evaluate and treat a patient with suspected B‑complex vitamin deficiency who has nighttime tremors?
Can a scopolamine transdermal patch cause nausea and vomiting?
In iron‑deficiency restless‑legs syndrome, which slow‑release intravenous iron preparation is preferred over iron sucrose and what is its recommended dosing schedule?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.